Abstract:Recent studies have demonstrated that Cbl, the 120-kDa protein product of the c-cbl proto-oncogene, serves as a substrate of a number of receptor-coupled tyrosine kinases and forms complexes with SH3 and SH2 domain-containing proteins, pointing to its role in signal transduction. Based on genetic evidence that the Caenorhabditis elegans Cbl homolog, SLI-1, functions as a negative regulator of the LET-23 receptor tyrosine kinase and our demonstration that Cbl's evolutionarily conserved N-terminal transforming region (Cbl-N; residues 1 to 357) harbors a phosphotyrosine binding (PTB) domain that binds to activated ZAP-70 tyrosine kinase, we examined the possibility that oncogenic Cbl mutants may activate mitogenic signaling by deregulating cellular tyrosine kinase machinery. Here, we show that expression of Cbl-N and two other transforming Cbl mutants (CblY368 delta and Cbl366-382 delta or Cb170Z), but not wild-type Cbl, in NIH 3T3 fibroblasts leads to enhancement of endogenous tyrosine kinase signaling. We identified platelet-derived growth factor receptor alpha (PDGFR alpha) as one target of mutant Cbl-induced deregulation. In mutant Cbl transfectants, PDGFR alpha was hyperphosphorylated and constitutively complexed with a number of SH2 domain-containing proteins. PDGFR alpha hyperphosphorylation and enhanced proliferation of mutant Cbl-transfected NIH 3T3 cells were drastically reduced upon serum starvation, and PDGF-AA substituted for the maintenance of these traits. PDGF-AA stimulation of serum-starved Cbl transfectants induced the in vivo association of transfected Cbl proteins with PDGFR alpha. In vitro, Cbl-N directly bound to PDGFR alpha derived from PDGF-AA-stimulated cells but not to that from unstimulated cells, and this binding was abrogated by a point mutation (G306E) corresponding to a loss-of-function mutation in SLI-1. The Cbl-N/G306E mutant protein, which failed to induce enhanced growth and transformation of NIH 3T3 cells, also failed to induce hyperphosphorylation of PDGFR alpha. Altogether, these findings identify a novel mechanism of Cbl's physiological function and oncogenesis, involving its PTB domain-dependent direct interaction with cellular tyrosine kinases.

Identification and Expression Analysis of an N-terminally Truncated Isoform of Human PDGF-C

PDGF-C Variant Mrna Expression in Renal Cell Carcinoma Cells

Expression of a Novel PDGF Isoform, PDGF-C, in Normal and Diseased Rat Kidney.

Platelet-derived Growth Factor D: Tumorigenicity in Mice and Dysregulated Expression in Human Cancer.

Identification Of A Novel Splice Variant Of Human Pd-L1 Mrna Encoding An Isoform-Lacking Igv-Like Domain

Identification and Expression Analysis of a Novel Splice Variant of Human Tumor Necrosis Factor Receptor Associated Factor 2

Expression and functional characterization of platelet-derived growth factor receptor-like gene.

Cloning and Identification of Two Novel Splice Variants of Human PD-L2.

PDGF-D is a Specific, Protease-Activated Ligand for the PDGF Β-Receptor

Expression and function of PDGF-C in development and stem cells

Identification and characterization of an alternative cancer-derived PD-L1 splice variant

Structural and Functional Analysis of Human PDGFR-β Promoter

Expression and purification of functional PDGF receptor beta

PDGF-D Prodomain Differentially Inhibits the Biological Activities of PDGF-D and PDGF-B

Glycosylation at Asn254 Is Required for the Activation of the PDGF-C Protein

PDGF-D is a Potent Transforming and Angiogenic Growth Factor

Two Platelet-derived Growth Factor Receptors in Vascular Smooth Muscle Cells.

Expression of the Fusion Proteins of PD-L2 Splice Isoforms with EGFP and Its Subcellular Localization

Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity

Post-Transcriptional Up-Regulation of PDGF-C by HuR in Advanced and Stressed Breast Cancer

Angiogenesis Stimulated by PDGF-CC, a Novel Member in the PDGF Family, Involves Activation of PDGFR-alphaalpha and -Alphabeta Receptors.